CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8+CD39+ regulatory T cells

European Journal of Immunology

Volumn 43, Issue 7, 2013, Pages 1925-1932

  Boer, Mardi C ^a   Van Meijgaarden, Krista E ^a   Bastid, Jérémy ^b   Ottenhoff, Tom H M ^a   Joosten, Simone A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b OREGA Biotech   (France)

Author keywords

BCG; CD39; CD8+ regulatory T (Treg) cell; Tuberculosis

Indexed keywords

BCG VACCINE; CD39 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE ACTIVATION GENE 3; LYMPHOCYTE ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANTIGEN FUNCTION; ARTICLE; CD8 CD39 REGULATORY T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL;

BCG; CD39; CD8+ REGULATORY T (TREG) CELL; TUBERCULOSIS;

ANTIGENS, CD; APYRASE; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; MYCOBACTERIUM BOVIS; T-LYMPHOCYTE SUBSETS;

EID: 84880000381     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243286     Document Type: Article

References (40)

1. World Health Organization. Global tuberculosis control. 2011 http://www.who.int/tb/publications/global_report/en/index.html.
2. Ottenhoff, T. H., New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol. 2012. 20: 419-428.
3. Shafiani, S., Tucker-Heard, G., Kariyone, A., Takatsu, K. and Urdahl, K. B., Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 2010. 207: 1409-1420.
4. Kursar, M., Koch, M., Mittrucker, H. W., Nouailles, G., Bonhagen, K., Kamradt, T. and Kaufmann, S. H., Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 2007. 178: 2661-2665.
5. Scott-Browne, J. P., Shafiani, S., Tucker-Heard, G., Ishida-Tsubota, K., Fontenot, J. D., Rudensky, A. Y., Bevan, M. J. et al., Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 2007. 204: 2159-2169.
6. Joosten, S. A. and Ottenhoff, T. H., Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination. Hum. Immunol. 2008. 69: 760-770.
7. Hanekom, W. A., The immune response to BCG vaccination of newborns. Ann. NY Acad. Sci. 2005. 1062: 69-78.
8. + regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl. Acad. Sci. USA 2007. 104: 8029-8034.
9. Ottenhoff, T. H., Elferink, D. G., Klatser, P. R. and de Vries, R. R., Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature 1986. 322: 462-464.
10. Modlin, R. L., Kato, H., Mehra, V., Nelson, E. E., Fan, X. D., Rea, T. H., Pattengale, P. K. et al., Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature 1986. 322: 459-461.
11. Mills, K. H., Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 2004. 4: 841-855.
12. + T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB. J. Immunol. 2012. 188: 4278-4288.
13. Joosten, S. A., van Meijgaarden, K. E., van Weeren, P. C., Kazi, F., Geluk, A., Savage, N. D., Drijfhout, J. W. et al., Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T cells with cytotoxic as well as regulatory activity. PLoS Pathog. 2010. 6: e1000782.
14. + suppressor T cells resurrected. Hum. Immunol. 2008. 69: 715-720.
15. Dwyer, K. M., Deaglio, S., Gao, W., Friedman, D., Strom, T. B. and Robson, S. C., CD39 and control of cellular immune responses. Purinergic. Signal. 2007. 3: 171-180.
16. Mandapathil, M., Lang, S., Gorelik, E. and Whiteside, T. L., Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J. Immunol. Methods 2009. 346: 55-63.
17. + T cells by magnetic beads reveals two phenotypically and functionally different subsets. J. Immunol. Methods 2011. 369: 59-68.
18. Chiacchio, T., Casetti, R., Butera, O., Vanini, V., Carrara, S., Girardi, E., Di, M. D. et al., Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis. Clin. Exp. Immunol. 2009. 156: 463-470.
19. + CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. J. Immunol. 2010. 184: 1690-1701.
20. Robson, S. C., Sevigny, J. and Zimmermann, H., The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic. Signal. 2006. 2: 409-430.
21. Trautmann, A., Extracellular ATP in the immune system: more than just a "danger signal". Sci. Signal. 2009. 2: e6.
22. Kusner, D. J. and Barton, J. A., ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. J. Immunol. 2001. 167: 3308-3315.
23. Kusner, D. J. and Adams, J., ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J. Immunol. 2000. 164: 379-388.
24. Stober, C. B., Lammas, D. A., Li, C. M., Kumararatne, D. S., Lightman, S. L. and McArdle, C. A., ATP-mediated killing of Mycobacterium bovis bacille Calmette-Guerin within human macrophages is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes. J. Immunol. 2001. 166: 6276-6286.
25. Fairbairn, I. P., Stober, C. B., Kumararatne, D. S. and Lammas, D. A., ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J. Immunol. 2001. 167: 3300-3307.
26. Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, H. et al., ATP drives lamina propria T(H)17 cell differentiation. Nature 2008. 455: 808-812.
27. Griffiths, K. L., Pathan, A. A., Minassian, A. M., Sander, C. R., Beveridge, N. E., Hill, A. V., Fletcher, H. A. et al., Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A. PLoS ONE 2011. 6: e23463.
28. Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A. et al., Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 2004. 22: 657-682.
29. Kaufmann, S. H., How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 2001. 1: 20-30.
30. Ottenhoff, T. H. and Kaufmann, S. H., Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 2012. 8: e1002607.
31. Ottenhoff, T. H., The knowns and unknowns of the immunopathogenesis of tuberculosis [state of the art]. Int. J. Tuberc. Lung Dis. 2012. 16: 1424-1432.
32. Britten, C. M., Janetzki, S., Butterfield, L. H., Ferrari, G., Gouttefangeas, C., Huber, C., Kalos, M. et al., T cell assays and MIATA: the essential minimum for maximum impact. Immunity 2012. 37: 1-2.
33. +-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness. J. Immunol. 2009. 183: 6157-6166.
34. Geluk, A., van Meijgaarden, K. E., Janson, A. A., Drijfhout, J. W., Meloen, R. H., de Vries, R. R. and Ottenhoff, T. H., Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J. Immunol. 1992. 149: 2864-2871.
35. Levesque, S. A., Lavoie, E. G., Lecka, J., Bigonnesse, F. and Sevigny, J., Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br. J. Pharmacol. 2007. 152: 141-150.
36. Bastid, J., Cottalorda-Regairaz, A., Alberici, G., Bonnefoy, N., Eliaou, J. F. and Bensussan, A., ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene 2013. 32: 1743-1751.
37. Nikolova, M., Carriere, M., Jenabian, M. A., Limou, S., Younas, M., Kok, A., Hue, S. et al., CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog. 2011. 7: e1002110.
38. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 2007. 8: 369-377.
39. Ye, Z. J., Zhou, Q., Du, R. H., Li, X., Huang, B. and Shi, H.Z., Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion. Clin. Vaccine Immunol. 2011. 18: 1608-1615.
40. de Cassan, S. C., Pathan, A. A., Sander, C. R., Minassian, A., Rowland, R., Hill, A. V., McShane, H. et al., Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A. Clin. Vaccine Immunol. 2010. 17: 1066-1073.